BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Le Ray A, Vert M, Gautier J, Benoît J. Fate of [14C]poly(DL-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice. International Journal of Pharmaceutics 1994;106:201-11. [DOI: 10.1016/0378-5173(94)90003-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cammas S, Kataoka K. Site Specific Drug-Carriers : Polymeric Micelles as High Potential Vehicles for Biologically Active Molecules. In: Webber SE, Munk P, Tuzar Z, editors. Solvents and Self-Organization of Polymers. Dordrecht: Springer Netherlands; 1996. pp. 83-113. [DOI: 10.1007/978-94-009-0333-3_6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
2 Vyas SP, Gupta PN. Implication of nanoparticles/microparticles in mucosal vaccine delivery. Expert Review of Vaccines 2014;6:401-18. [DOI: 10.1586/14760584.6.3.401] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
3 Navarro SM, Morgan TW, Astete CE, Stout RW, Coulon D, Mottram P, Sabliov CM. Biodistribution and toxicity of orally administered poly (lactic-co-glycolic) acid nanoparticles to F344 rats for 21 days. Nanomedicine 2016;11:1653-69. [DOI: 10.2217/nnm-2016-0022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
4 Poon W, Zhang Y, Ouyang B, Kingston BR, Wu JLY, Wilhelm S, Chan WCW. Elimination Pathways of Nanoparticles. ACS Nano 2019;13:5785-98. [DOI: 10.1021/acsnano.9b01383] [Cited by in Crossref: 99] [Cited by in F6Publishing: 90] [Article Influence: 49.5] [Reference Citation Analysis]
5 Banakar UV. Advances and opportunities in delivery of therapeutic proteins and peptides. J Biomater Appl 1997;11:377-429. [PMID: 9178093 DOI: 10.1177/088532829701100402] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
6 Lavelle E, Sharif S, Thomas N, Holland J, Davis S. The importance of gastrointestinal uptake of particles in the design of oral delivery systems. Advanced Drug Delivery Reviews 1995;18:5-22. [DOI: 10.1016/0169-409x(95)00048-c] [Cited by in Crossref: 75] [Article Influence: 2.9] [Reference Citation Analysis]
7 Lakkireddy HR, Bazile D. Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))–poly(ethylene glycol) nanotechnology as a model: An industrial viewpoint. Advanced Drug Delivery Reviews 2016;107:289-332. [DOI: 10.1016/j.addr.2016.08.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
8 Keegan ME, Whittum-hudson JA, Mark Saltzman W. Biomimetic design in microparticulate vaccines. Biomaterials 2003;24:4435-43. [DOI: 10.1016/s0142-9612(03)00351-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Mu L, Seow P, Ang S, Feng S. Study on surfactant coating of polymeric nanoparticles for controlled delivery of anticancer drug. Colloid Polym Sci 2004;283:58-65. [DOI: 10.1007/s00396-004-1090-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
10 Felder C, Vorlaender N, Gander B, Merkle H, Bertschinger H. Microencapsulated enterotoxigenic Escherichia coli and detached fimbriae for peroral vaccination of pigs. Vaccine 2000;19:706-15. [DOI: 10.1016/s0264-410x(00)00264-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
11 Li J, Zhou P, Wang Y, Chen H, Zhang C, Li R, Yang X, Wang Y. N-lauroyl chitosan surface-modified PLGA nanoparticles as carrier for adriamycin to overcome cancer drug resistance. J Microencapsul 2014;31:203-10. [PMID: 23937210 DOI: 10.3109/02652048.2013.824515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Hillery AM, Toth I, Shaw AJ, Florence AT. Co-polymerised peptide particles (CPP) I: synthesis, characterisation and in vitro studies on a novel oral nanoparticulate delivery system. Journal of Controlled Release 1996;41:271-81. [DOI: 10.1016/0168-3659(96)01342-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
13 Torché A, Jouan H, Le Corre P, Albina E, Primault R, Jestin A, Le Verge R. Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer’s patch segment. International Journal of Pharmaceutics 2000;201:15-27. [DOI: 10.1016/s0378-5173(00)00364-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
14 Leroux J, Cozens R, L.roesel J, Galli B, Kubel F, Doelker E, Gurny R. Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to Mice. Journal of Pharmaceutical Sciences 1995;84:1387-91. [DOI: 10.1002/jps.2600841202] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 1.8] [Reference Citation Analysis]
15 Löbenberg R, Araujo L, Kreuter J. Body distribution of azidothymidine bound to nanoparticles after oral administration. European Journal of Pharmaceutics and Biopharmaceutics 1997;44:127-32. [DOI: 10.1016/s0939-6411(97)00078-7] [Cited by in Crossref: 50] [Article Influence: 2.1] [Reference Citation Analysis]
16 Eyles JE, Alpar HO, Conway BR, Keswick M. Oral Delivery and Fate of Poly(lactic acid) Microsphere-encapsulated Interferon in Rats. Journal of Pharmacy and Pharmacology 1997;49:669-74. [DOI: 10.1111/j.2042-7158.1997.tb06090.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Torché A, Le Corre P, Albina E, Le Verge R. PLGA Microspheres Phagocytosis by Pig Alveolar Macrophages: Influence of Polyvinyl alcohol) Concentration, Nature of Loaded-Protein and Copolymer Nature. Journal of Drug Targeting 2009;7:343-54. [DOI: 10.3109/10611869909085517] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
18 Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opinion on Drug Delivery 2008;5:155-74. [DOI: 10.1517/17425247.5.2.155] [Cited by in Crossref: 146] [Cited by in F6Publishing: 124] [Article Influence: 11.2] [Reference Citation Analysis]
19 Patel G, Misra A. Oral Delivery of Proteins and Peptides. Challenges in Delivery of Therapeutic Genomics and Proteomics. Elsevier; 2011. pp. 481-529. [DOI: 10.1016/b978-0-12-384964-9.00010-4] [Cited by in Crossref: 9] [Article Influence: 0.9] [Reference Citation Analysis]
20 Sahu P, Kashaw SK, Kushwah V, Sau S, Jain S, Iyer AK. pH responsive biodegradable nanogels for sustained release of bleomycin. Bioorg Med Chem 2017;25:4595-613. [PMID: 28734664 DOI: 10.1016/j.bmc.2017.06.038] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 9.5] [Reference Citation Analysis]
21 Kumar M, Sharma P, Maheshwari R, Tekade M, Shrivastava SK, Tekade RK. Beyond the Blood–Brain Barrier. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors. Elsevier; 2018. pp. 397-437. [DOI: 10.1016/b978-0-12-812218-1.00015-4] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Lu W, Guo J, Zhou J, Ke L, Liu S, Gao G, Wang H, Ding W, Rao P. Hypothesis review: The direct interaction of food nanoparticles with the lymphatic system. Food Science and Human Wellness 2012;1:61-4. [DOI: 10.1016/j.fshw.2012.08.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tosi G, Rivasi F, Gandolfi F, Costantino L, Vandelli M, Forni F. Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles. Biomaterials 2005;26:4189-95. [DOI: 10.1016/j.biomaterials.2004.10.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
24 Ciftci K, Hincal AA, Kas HS, Ercan TM, Sungur A, Guven O, Ruacan S. Solid Tumor Chemotherapy and in Vivo Distribution of Fluorouracil Following Administration in Poly(L-Lactic Acid) Microspheres. Pharmaceutical Development and Technology 2008;2:151-60. [DOI: 10.3109/10837459709022620] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
25 Vergoni AV, Tosi G, Tacchi R, Vandelli MA, Bertolini A, Costantino L. Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution. Nanomedicine 2009;5:369-77. [PMID: 19341816 DOI: 10.1016/j.nano.2009.02.005] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 8.2] [Reference Citation Analysis]
26 Carr KE, Smyth SH, Mccullough MT, Morris JF, Moyes SM. Morphological aspects of interactions between microparticles and mammalian cells: intestinal uptake and onward movement. Progress in Histochemistry and Cytochemistry 2012;46:185-252. [DOI: 10.1016/j.proghi.2011.11.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
27 Gaucher G, Asahina K, Wang J, Leroux J. Effect of Poly( N -vinyl-pyrrolidone)- block -poly( d , l -lactide) as Coating Agent on the Opsonization, Phagocytosis, and Pharmacokinetics of Biodegradable Nanoparticles. Biomacromolecules 2009;10:408-16. [DOI: 10.1021/bm801178f] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 8.3] [Reference Citation Analysis]
28 Mcclean S, Prosser E, Meehan E, O'malley D, Clarke N, Ramtoola Z, Brayden D. Binding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia. European Journal of Pharmaceutical Sciences 1998;6:153-63. [DOI: 10.1016/s0928-0987(97)10007-0] [Cited by in Crossref: 199] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
29 Gautier S, Grudzielski N, Goffinet G, De Hassonville SH, Delattre L, Jérôme R. Preparation of poly(D,L-lactide) nanoparticles assisted by amphiphilic poly(methyl methacrylate-co-methacrylic acid) copolymers. Journal of Biomaterials Science, Polymer Edition 2001;12:429-50. [DOI: 10.1163/156856201750195306] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
30 Gref R, Domb A, Quellec P, Blunk T, Müller R, Verbavatz J, Langer R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Advanced Drug Delivery Reviews 2012;64:316-26. [DOI: 10.1016/j.addr.2012.09.008] [Cited by in Crossref: 121] [Cited by in F6Publishing: 85] [Article Influence: 13.4] [Reference Citation Analysis]
31 Bakhru SH, Furtado S, Morello AP, Mathiowitz E. Oral delivery of proteins by biodegradable nanoparticles. Adv Drug Deliv Rev. 2013;65:811-821. [PMID: 23608641 DOI: 10.1016/j.addr.2013.04.006] [Cited by in Crossref: 122] [Cited by in F6Publishing: 109] [Article Influence: 15.3] [Reference Citation Analysis]
32 Costantino L. Drug delivery to the CNS and polymeric nanoparticulate carriers. Future Medicinal Chemistry 2010;2:1681-701. [DOI: 10.4155/fmc.10.249] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
33 Santos ID, Morgat J, Vert M. A route to high radioactivity3H-labelled PLA polymers. Polym Int 1999;48:283-7. [DOI: 10.1002/(sici)1097-0126(199904)48:4<283::aid-pi123>3.0.co;2-v] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
34 Dong Y, Feng S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004;25:2843-9. [DOI: 10.1016/j.biomaterials.2003.09.055] [Cited by in Crossref: 352] [Cited by in F6Publishing: 326] [Article Influence: 20.7] [Reference Citation Analysis]
35 Vila A, Sánchez A, Tobío M, Calvo P, Alonso MJ. Design of biodegradable particles for protein delivery. J Control Release. 2002;78:15-24. [PMID: 11772445 DOI: 10.1016/s0168-3659(01)00486-2] [Cited by in Crossref: 410] [Cited by in F6Publishing: 63] [Article Influence: 21.6] [Reference Citation Analysis]
36 Gupta PN. Mucosal Vaccine Delivery and M Cell Targeting. In: Devarajan PV, Jain S, editors. Targeted Drug Delivery : Concepts and Design. Cham: Springer International Publishing; 2015. pp. 313-37. [DOI: 10.1007/978-3-319-11355-5_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Gref R, Babak V, Bouillot P, Lukina I, Bodorev M, Dellacherie E. Interfacial and emulsion stabilising properties of amphiphilic water-soluble poly(ethylene glycol)–poly(lactic acid) copolymers for the fabrication of biocompatible nanoparticles. Colloids and Surfaces A: Physicochemical and Engineering Aspects 1998;143:413-20. [DOI: 10.1016/s0927-7757(98)00524-x] [Cited by in Crossref: 21] [Article Influence: 0.9] [Reference Citation Analysis]
38 Oh I, Lee K, Kwon HY, Lee YB, Shin SC, Cho CS, Kim CK. Release of adriamycin from poly(gamma-benzyl-L-glutamate)/poly(ethylene oxide) nanoparticles. Int J Pharm 1999;181:107-15. [PMID: 10370207 DOI: 10.1016/s0378-5173(99)00012-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
39 Plard J, Bazile D. Comparison of the safety profiles of PLA50 and Me.PEG-PLA50 nanoparticles after single dose intravenous administration to rat. Colloids and Surfaces B: Biointerfaces 1999;16:173-83. [DOI: 10.1016/s0927-7765(99)00068-5] [Cited by in Crossref: 48] [Article Influence: 2.2] [Reference Citation Analysis]
40 Tobı́o M, Sánchez A, Vila A, Soriano I, Evora C, Vila-jato J, Alonso M. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloids and Surfaces B: Biointerfaces 2000;18:315-23. [DOI: 10.1016/s0927-7765(99)00157-5] [Cited by in Crossref: 254] [Cited by in F6Publishing: 44] [Article Influence: 12.1] [Reference Citation Analysis]
41 Löbenberg R, Maas J, Kreuter J. Improved Body Distribution of 14 C-labelled AZT bound to Nanoparticles in Rats determined by Radioluminography. Journal of Drug Targeting 2009;5:171-9. [DOI: 10.3109/10611869808995872] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
42 Manju S, Sreenivasan K. Synthesis and characterization of a cytotoxic cationic polyvinylpyrrolidone-curcumin conjugate. J Pharm Sci 2011;100:504-11. [PMID: 20848656 DOI: 10.1002/jps.22278] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]